US Patent Litigations are now available. Check here

Explore Lonza Biologics's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Patent NumberGrant DateTitleTotal Oppositions
EP1915394Jan 27, 2021High-Level Expression Of Recombinant Antibody In A Mammalian Host Cell6
EP2467400Jan 24, 2018Variant Immunoglobulins With Improved Manufacturability2